BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15147356)

  • 21. Correlation between conformation and antibody binding: NMR structure of cross-reactive peptides from T. cruzi, human and L. braziliensis.
    Soares MR; Bisch PM; Campos de Carvalho AC; Valente AP; Almeida FC
    FEBS Lett; 2004 Feb; 560(1-3):134-40. PubMed ID: 14988012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens.
    Masuda MO; Levin M; De Oliveira SF; Dos Santos Costa PC; Bergami PL; Dos Santos Almeida NA; Pedrosa RC; Ferrari I; Hoebeke J; Campos de Carvalho AC
    FASEB J; 1998 Nov; 12(14):1551-8. PubMed ID: 9806764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulatory effects on myocardial physiology induced by an anti-Trypanosoma cruzi monoclonal antibody involve recognition of major antigenic epitopes from beta1-adrenergic and M2-muscarinic cholinergic receptors without requiring receptor cross-linking.
    Cremaschi G; Fernández MM; Gorelik G; Goin JC; Fossati CA; Zwirner NW; Malchiodi EL
    J Neuroimmunol; 2004 Aug; 153(1-2):99-107. PubMed ID: 15265668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease.
    Gironès N; Rodríguez CI; Basso B; Bellon JM; Resino S; Muñoz-Fernández MA; Gea S; Moretti E; Fresno M
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1039-43. PubMed ID: 11687436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal dysfunction in patients with chronic Chagas' disease is associated to anti-Trypanosoma cruzi antibodies that cross-react with rhodopsin.
    Matsumoto SC; Labovsky V; Roncoroni M; Guida MC; Giménez L; Mitelman J; Gori H; Jurgelevicius R; Grillo A; Manfredi P; Levin MJ; Paveto C
    FASEB J; 2006 Mar; 20(3):550-2. PubMed ID: 16423878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease.
    Elies R; Ferrari I; Wallukat G; Lebesgue D; Chiale P; Elizari M; Rosenbaum M; Hoebeke J; Levin MJ
    J Immunol; 1996 Nov; 157(9):4203-11. PubMed ID: 8892658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope.
    Mesri EA; Levitus G; Hontebeyrie-Joskowicz M; Dighiero G; Van Regenmortel MH; Levin MJ
    J Clin Microbiol; 1990 Jun; 28(6):1219-24. PubMed ID: 1696282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chagas' disease cardioneuropathy: association of anti-Trypanosoma cruzi and anti-sciatic nerve antibodies.
    Gea S; Ordonez P; Cerban F; Iosa D; Chizzolini C; Vottero-Cima E
    Am J Trop Med Hyg; 1993 Nov; 49(5):581-8. PubMed ID: 7504407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA immunization with the ribosomal P2beta gene of Trypanosoma cruzi fails to induce pathogenic antibodies.
    Levitus G; Grippo V; Labovsky V; Ghio S; Hontebeyrie M; Levin MJ
    Microbes Infect; 2003 Dec; 5(15):1381-8. PubMed ID: 14670451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of autoantibodies in the physiopathology of Chagas' disease.
    Medei EH; Nascimento JH; Pedrosa RC; Carvalho AC
    Arq Bras Cardiol; 2008 Oct; 91(4):257-62, 281-6. PubMed ID: 19009179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chagas' disease: humoral response to subcellular fraction of Trypanosoma cruzi in symptomatic and asymptomatic patients.
    de Titto EH; Moreno M; Braun M; Segura EL
    Trop Med Parasitol; 1987 Sep; 38(3):163-6. PubMed ID: 3124252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vimentin and Anti Vimentin Antibodies in Chagas' Disease.
    Nascimento MS; Stolf AMS; Andrade Junior HF; Pandey RP; Umezawa ES
    Arq Bras Cardiol; 2018 Apr; 110(4):348-353. PubMed ID: 29538505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of anti-R-13 antibodies in human Trypanosoma cruzi infection.
    Aznar C; Lopez-Bergami P; Brandariz S; Mariette C; Liegeard P; Alves MD; Barreiro EL; Carrasco R; Lafon S; Kaplan D
    FEMS Immunol Med Microbiol; 1995 Dec; 12(3-4):231-8. PubMed ID: 8745008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chronic presence of the parasite, and anti-P autoimmunity in Chagas disease: the Trypanosoma cruzi ribosomal P proteins, and their recognition by the host immune system.
    Kaplan D; Vazquez M; Lafon S; Schijman AG; Levitus G; Levin MJ
    Biol Res; 1993; 26(1-2):273-7. PubMed ID: 7545503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein.
    Díez H; Guzmán F; Alba MP; Cuéllar A; Thomas MC; López MC; Rosas F; Velasco V; González JM; Patarroyo ME; Puerta CJ
    Peptides; 2007 Aug; 28(8):1520-6. PubMed ID: 17683828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology.
    Thomas MC; Fernández-Villegas A; Carrilero B; Marañón C; Saura D; Noya O; Segovia M; Alarcón de Noya B; Alonso C; López MC
    Clin Vaccine Immunol; 2012 Feb; 19(2):167-73. PubMed ID: 22155766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease.
    Almeida IC; Ferguson MA; Schenkman S; Travassos LR
    Braz J Med Biol Res; 1994 Feb; 27(2):443-7. PubMed ID: 8081263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A; Sousa OE
    J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
    Almeida IC; Ferguson MA; Schenkman S; Travassos LR
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies from Trypanosoma cruzi infected mice recognize the second extracellular loop of the beta 1-adrenergic and M2-muscarinic receptors and regulate calcium channels in isolated cardiomyocytes.
    Mijares A; Verdot L; Peineau N; Vray B; Hoebeke J; Argibay J
    Mol Cell Biochem; 1996; 163-164():107-12. PubMed ID: 8974045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.